Evgen Pharma (GB:TCF) has released an update.
TheraCryf plc, a clinical-stage drug development company specializing in oncology and neuropsychiatry, has announced the posting of their Annual Report for the year ending March 31, 2024, and has scheduled their AGM for July 18, 2024. The report is now accessible on their website, and the AGM will be held at the Alderley Park Conference Centre in the UK. The company, known for partnering with mid-to-large pharma for clinical trials and commercialization, is listed on the AIM market under the ticker TCF.
For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.
